Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedResults were posted for NCT03325101 (Results First Posted 2025-06-12), and the study status was updated to Terminated due to poor accrual.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check45 days agoChange DetectedAdds Melanoma as a MedlinePlus topic and updates to revision v3.1.0; removes the older Melanoma, Cutaneous Malignant topic and revision v3.0.2.SummaryDifference0.3%

- Check59 days agoChange DetectedRevision: v3.0.2 replaces v3.0.1; the 'Back to Top' link was removed, a minor UI adjustment.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of new medical procedures and therapies related to skin and connective tissue diseases, while also removing several previous references to locations and specific medical topics.SummaryDifference2%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.